Shares of ALPS Group Inc Ordinary Share (NASDAQ:ALPS - Free Report) are scheduled to reverse split on the morning of Monday, November 9th. The 1-5 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, November 8th.
ALPS Group Inc Ordinary Share Stock Performance
ALPS traded down $0.00 on Monday, hitting $0.32. The company had a trading volume of 89,848 shares, compared to its average volume of 65,188. The stock has a market capitalization of $53.96 million, a price-to-earnings ratio of 1.25 and a beta of -0.08. ALPS Group Inc Ordinary Share has a 12-month low of $0.23 and a 12-month high of $1.75. The stock has a fifty day moving average price of $0.37 and a 200-day moving average price of $0.56.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of ALPS Group Inc Ordinary Share in a report on Friday, October 2nd. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company presently has a consensus rating of "Sell".
View Our Latest Report on ALPS
Institutional Inflows and Outflows
A hedge fund recently raised its position in ALPS Group Inc Ordinary Share stock. SkyView Investment Advisors LLC lifted its position in shares of ALPS Group Inc Ordinary Share (NASDAQ:ALPS - Free Report) by 1,000.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 110,000 shares of the company's stock after purchasing an additional 100,000 shares during the period. SkyView Investment Advisors LLC owned about 0.07% of ALPS Group Inc Ordinary Share worth $64,000 at the end of the most recent reporting period. Institutional investors own 27.90% of the company's stock.
About ALPS Group Inc Ordinary Share
(
Get Free Report)
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ALPS Group Inc Ordinary Share, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ALPS Group Inc Ordinary Share wasn't on the list.
While ALPS Group Inc Ordinary Share currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.